Bris­tol My­ers takes on au­toim­mune dis­eases with cell ther­a­py, plus new da­ta from Ca­balet­ta and Kyver­na

Bris­tol My­ers Squibb re­cent­ly pre­sent­ed da­ta for the first time from its clin­i­cal tri­al of a cell ther­a­py for au­toim­mune dis­eases, which has quick­ly be­come …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.